A phase 2 study of CMB305 and atezolizumab in NY-ESO-1+soft tissue sarcoma: Interim analysis of immunogenicity, tumor control and survival

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Chawla, S; Van Tine, BA; Pollack, S; Ganjoo, K; Elias, A; Riedel, RF; Attia, S; Choy, E; Okuno, S; Agulnik, M; von Mehren, M; Livingston, M; Keedy, V; Verschraegen, C; Philip, T; Bohac, C; Lu, H; Chen, M; Maki, R

Published Date

  • September 1, 2017

Published In

Volume / Issue

  • 28 /

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Conference Location

  • Madrid, SPAIN

Conference Start Date

  • September 8, 2017

Conference End Date

  • September 12, 2017